Syphilis, HIV and HCV pose significant health risks for women, often with long-term medical implications. Challenges in diagnosis and treatment persist along with a lack of awareness and understanding of women’s symptoms. This webinar will explore how rapid point-of-care testing is a critical tool in helping improve women’s health outcomes.
Learning Objectives:
- Understand the burden of syphilis, HIV and HCV in women
- Discuss the benefits of rapid point-of-care tests, including prompt linkage to care
- Explore use cases and effective strategies for integrating rapid syphilis, HIV and HCV testing into practice
Sponsored by:
OraSure Technologies, Inc., with subsidiaries DNA Genotek and Sherlock Biosciences, leads in the development, manufacture and distribution of rapid diagnostic tests and sample collection/stabilization devices for critical medical conditions. Our products are sold globally to clinical labs, hospitals, clinics, public health organizations, research institutions, government agencies, pharma companies, commercial entities, and consumers. OraSure connects people to healthcare with innovative, effortless solutions.
The complimentary webinar applies to clinical practice. No CNE is being awarded.